Morgan Stanley’s Tenon Medical TNON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61 Hold
5
﹤0.01% 8046
2026
Q1
$136 Hold
5
﹤0.01% 7746
2025
Q4
$179 Hold
5
﹤0.01% 7642
2025
Q3
$222 Hold
5
﹤0.01% 7591
2025
Q2
$184 Hold
5
﹤0.01% 7584
2025
Q1
$397 Sell
5
-8
-62% -$449 ﹤0.01% 7403
2024
Q4
$831 Sell
13
-9
-41% -$923 ﹤0.01% 7300
2024
Q3
$3.19K Buy
+22
New +$3.71K ﹤0.01% 7029
2024
Q2
Hold
0
7799
2024
Q1
Hold
0
7768
2023
Q4
Hold
0
7724
2023
Q3
Hold
0
7427
2023
Q2
Sell
-9
Closed -$33.1K 7433
2023
Q1
$43.2K Buy
9
+1
+13% +$5.53K ﹤0.01% 6335
2022
Q4
$34.7K Sell
8
-9
-53% -$45.9K ﹤0.01% 6445
2022
Q3
$62K Buy
17
+9
+113% +$52.5K ﹤0.01% 6308
2022
Q2
$47K Buy
+8
New +$233K ﹤0.01% 6642

Other funds holding TNON

Morgan Stanley's TNON Position: Q2 2026 in Review

Morgan Stanley held its Tenon Medical (TNON) position steady in Q2 2026 at 5 shares worth $61. The position accounts for ﹤0.01% of the portfolio, ranked #8046.

Morgan Stanley first reported a position in TNON in Q2 2022 and has held it in 12 quarters since. The position peaked at $62K in Q3 2022. 13 funds tracked by Wall St. Rank hold TNON as of Q2 2026.

  • Morgan Stanley held 5 shares of Tenon Medical worth $61 as of Q2 2026.
  • Morgan Stanley left its Tenon Medical share count unchanged in Q2 2026.
  • Tenon Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8046 holding.
  • Morgan Stanley first reported a position in Tenon Medical in Q2 2022 and has held it in 12 quarters since.
  • Morgan Stanley's Tenon Medical position peaked at $62K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held Tenon Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.